99
Profiles in the current library
99 profiles in published library edition 6, with cited evidence and clearly labeled related non-peptide references. Latest source check: November 8, 2026; individual review dates remain visible.
Peptide education. Private progress.
Understand the evidence. Organize your own records. Bring more context to your next clinician conversation—all in one private iPhone app.
Explore the sample preview before subscribing. No app account required.
99 profiles · Library updated November 8, 2026 ↗

Evidence Lens · Go beyond the headline
A claim is only the beginning. Explore how it is supported, follow its sources, and keep the uncertainties in view.
Distinguish animal research, human trials, approved labeling, and safety notices. Counts represent claims—not a score for safety or effectiveness.
Open its attached references and plain-language context. No unrelated sources are substituted.
Research filters keep safety and uncertainty accessible. Evidence type is never a personalized recommendation.
Evidence Lens is available now in 1.1.19. Update Peptide Clarity on the App Store to explore it.

Library updated November 8, 2026
Explore the latest published library, compare evidence coverage, revisit saved profiles, and follow evidence linked to your questions. Research, approved uses, and study limitations stay clearly separated.
99
99 profiles in published library edition 6, with cited evidence and clearly labeled related non-peptide references. Latest source check: November 8, 2026; individual review dates remain visible.
471
Updated research summaries and corrected study details keep findings, limitations, and product-specific approved uses clearly separated.
215
Follow the sources behind each claim. Clearer safety notes and age restrictions help you understand the context—not choose a treatment.
Released November 4, 2026. The app bundles 97 profiles, 460 claims and 208 references. The totals above describe published library edition 6, available through Check for library updates in Library Review. Research changes over time; review dates and citations help you judge the context. View the App Store listing ↗
The latest published library includes 99 profiles, 471 claims and 215 references. The November 8 update adds insulin icodec (Awiqli), insulin efsitora alfa (Onswik), and reviewed findings for semaglutide and orforglipron, with source limitations kept visible.
Version 1.1.19 added profiles for icotrokinra, enlicitide, navepegritide, and bulevirtide. Its plan screen also links directly to Apple’s standard Terms of Use (EULA).
Open Library Review and choose Check for library updates, or pull to refresh Library. Published updates are available in app version 1.1.15 or later; after a successful download, the library remains available offline.
Editorial dates do not indicate new approval or live checks. This update history begins September 30, 2026. Research summaries remain educational, with study limitations kept in view.
Submitted November 8, 2026. Version 1.1.20 bundles library edition 6 for offline use: 99 profiles, 471 claims and 215 references. It includes insulin icodec (Awiqli), insulin efsitora alfa (Onswik), and new reviewed findings for semaglutide and orforglipron. This library content is already available in compatible installed versions through Check for library updates; the new app version itself still requires Apple approval.
This app update is not yet available in the App Store. Availability depends on Apple approval and release. The current download is version 1.1.19.
Available now in 1.1.19
Check
Find related reviewed statements and their sources. Compare the exact wording, the evidence, and what is still uncertain.
Prepare
Save questions about a claim, study, or check-in. Choose your priorities in Visit Mode, share a report, then record answers and follow-ups.
Explore
The Evidence Map groups known source relationships and study overlaps, while keeping trial registrations separate from study results.

Available now. Compare a claim with reviewed library statements, then save your questions. Claim checks do not provide a diagnosis or a treatment recommendation.

Available now. Explore how the sources connect while keeping trial registrations separate from results. A source group is not a count of independent studies.
A look inside
Real screens from version 1.1.19, shown with sample records—not treatment recommendations or promised results. In the app, explore the sample preview before choosing a subscription. Nothing in that preview is saved. Library totals in these captures reflect the bundled edition; downloaded updates may differ.

99 curated profiles bring approval status, evidence summaries, safety context, and sources together. Related non-peptide references are clearly labeled.

See your own schedule and record completed or skipped entries. The app does not choose a treatment or dose for you.

Open your weekly Clarity Review for recorded changes, missing entries, and context. Choose which personal records to include in a clinician PDF.
Why full access
Move from cited education to today's personal record and a shareable progress summary. No ads, no separate app account, and no automated treatment recommendations.
Learn
Browse cited profiles with approved uses, investigational findings, safety context, and primary sources kept clearly separated.
Track
Organize the schedule you already follow, record completed or skipped entries, and use reminders that stay discreet by default.
Review
Review check-ins and trends over time, then create a neutral clinician-ready PDF containing only the records you choose.
Simple pricing · Full access
Both plans unlock the complete library, tracking, reminders, progress tools, private iCloud sync, and clinician-ready reports.
$3.99per month
Billed monthly
Flexible full access with the freedom to cancel through Apple at any time.
Get Peptide Clarity$14.99per year
About $1.25 per month
The complete experience for a full year while saving about 69% versus monthly.
Get Peptide ClarityU.S. subscriptions are $3.99 monthly or $14.99 yearly. Apple’s purchase confirmation shows the price and terms that apply to you; localized prices and availability may vary. Eligible new subscribers receive a 3-day free trial.
Subscriptions renew automatically unless canceled through Apple. If access expires, your existing records remain readable, exportable, and deletable; creating and editing records requires active access.
Full access includes
01
Your data
How Peptide Clarity handles private records, iCloud sync, photos, notifications, and exports.
02
Using the app
Educational-use terms, subscription details, medical disclaimer, and acceptable use.
03
Need help?
Get help with purchases, restoring access, iCloud sync, notifications, and using the app.
Important
Peptide Clarity does not diagnose, prescribe, recommend dosing, or replace a licensed healthcare professional. Seek qualified medical advice for personal treatment decisions and urgent care for emergencies.